PATENT CLAIM ANALYSIS

Application Number: 16171236
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "211100"]

Abstract:
The present invention relates to compounds of formula I wherein R 1 , R 2 , R 3 , R 4a , R 4b , R 4c , R 4d , L, A, Q, W and HET are each as defined herein. The compounds of the present invention are inhibitors of autotaxin (ATX) enzyme activity. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of proliferative disorders, such as cancer, as well as other diseases or conditions (e.g. fibrosis) in which ATX activity is implicated.

Claim (Index 48):
The method according to  claim 37 , wherein R 3  is selected from (1-6C)alkyl, phenyl, (4-8C)carbocyclyl, 5- or 6 membered heteroaryl or 4- to 6 membered heterocyclyl, each of which is optionally substituted with one or more substituents selected from (1-4C)alkyl, halo, (1-4C)fluoroalkyl, (1-4C)alkoxy, (1-4C)fluoroalkoxy, cyclopropyl, cyclobutyl, (2-4C)alkenyl or (2-4C)alkynyl;

Metadata:
- Claim Count in Document: 47.0
- Percentile: 97.0
- Lexical Diversity: 1.75758
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15547776', '15554354', '10718337', '15533804', '10922425']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7620510824156613
- 35 USC 102 Novelty (BERT): 0.6769898162738736
- Combined Prediction Score: 0.7535449558014826
- Mean Citation Score: 412.327196
- Max Citation Score: 672.92206
- Similarity Product: 645.5604715694427

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test